Skip to main content

Table 1 Demographics and clinical characteristics of patients with ampullary adenocarcinoma

From: Prognostic impact of immunohistochemical expression of CK7 and CK20 in curatively resected ampulla of Vater cancer

Variables  
Total number 37 (100 %)
Sex  
  Male 18 (48.6 %)
  Female 19 (51.4 %)
Age, years 62.57 ± 8.22
T stage  
  T1 14 (37.8 %)
  T2 8 (21.6 %)
  T3 14 (37.8 %)
  T4 1 (2.7 %)
N stage  
  N0 31 (83.8 %)
  N1 6 (16.2 %)
Overall stage  
  IA 14 (37.8 %)
  IB 6 (16.2 %)
  IIA 11 (29.7 %)
  IIB 5 (13.5 %)
  III 1 (2.7 %)
Tumor size (cm) 2.58 ± 1.49
CA19-9 (U/ml) 459.54 ± 1727.30
CEA (ng/ml) 4.03 ± 5.65
Lymphovascular invasion  
  No 31 (83.8 %)
  Yes 6 (16.2 %)
Perineural invasion  
  No 30 (81.1 %)
  Yes 7 (18.9 %)
Differentiation  
  Well/Moderately 31 (83.8 %)
  Poorly 6 (16.2 %)
Adjuvant therapy  
  No 20 (54.0 %)
  Yes 17 (46.0 %)
  1. CA19-9 Carbohydrate antigen 19–9, CEA Carcinoembryonic antigen